The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
Open accessAbstract
Background: The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in clinical trials may not translate to routine practice. We aimed to evaluate the effectiveness and safety of dabigatran, rivaroxaban, and apixaban by comparing each agent with warfarin. Methods and Results: Using a large US insurance database, we identified privately insured and Medicare Advantage patients with nonvalvular atrial fibrillation who were users of apixaban, dabigatran, rivaroxaban, or warfarin between October 1, 2010, and June 30, 2015. We created 3 matched cohorts using 1:1 propensity score matching: apixaban versus warfarin (n=15 390), dabigatran versus warfarin (n=28 614), and rivaroxaban versus warfarin (n=32 350). Using Cox proportional hazards regression, we found that for stroke or systemic embolism, apixaban was associated with lower risk (hazard ratio [ HR ] 0.67, 95% CI 0.46–0.98, P =0.04), but dabigatran and rivaroxaban were associated with a similar risk (dabigatran: HR 0.98, 95% CI 0.76–1.26, P =0.98; rivaroxaban: HR 0.93, 95% CI 0.72–1.19, P =0.56). For major bleeding, apixaban and dabigatran were associated with lower risk (apixaban: HR 0.45, 95% CI 0.34–0.59, P <0.001; dabigatran: HR 0.79, 95% CI 0.67–0.94, P <0.01), and rivaroxaban was associated with a similar risk ( HR 1.04, 95% CI 0.90–1.20], P =0.60). All non–vitamin K antagonist oral anticoagulants were associated with a lower risk of intracranial bleeding. Conclusions: In patients with nonvalvular atrial fibrillation, apixaban was associated with lower risks of both stroke and major bleeding, dabigatran was associated with similar risk of stroke but lower risk of major bleeding, and rivaroxaban was associated with similar risks of both stroke and major bleeding in comparison to warfarin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290 · cited 1×
“We conducted survival regression using the method of Fine and Gray and considering death as a competing risk.(63) The findings remained unchanged.”
MethodDabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 1×
“A standardized difference <10% was considered acceptable.(42) When conducting subgroup analyses, we also checked the balance of baseline characteristics within each subgroup.”
MethodProportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S., D’Agostino, R. B., Massaro, J. M., Beiser, A., Wolf, P. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000140263.20897.42 · Cited by 2,041
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01236-6 · Cited by 1,562
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081 · cited 1×
“Analyses of RE-LY data suggested a lower risk of major bleeding in patients aged <75 years but a trend toward higher risk in patients aged ≥75 years.(46) Moreover, physicians tended to prescribe medications to patients who were similar Table 4.”
ResultYusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014
Kokotailo, R. A., & Hill, M. D. (2005) · Stroke · doi:10.1161/01.str.0000174293.17959.a1 · Cited by 709
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects
Lavallée, P. C., Meseguer, E., Abboud, H., Cabrejo, L., Olivot, J.-M., Simon, O., Mazighi, M., Nifle, C., Niclot, P., Lapergue, B., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70248-x · Cited by 668
Validating Administrative Data in Stroke Research
Tirschwell, D. L., & Longstreth, W. T. (2002) · Stroke · doi:10.1161/01.str.0000032240.28636.bd · Cited by 658
Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012061 · Cited by 644
Death and Disability from Warfarin-Associated Intracranial and Extracranial Hemorrhages
Fang, M. C., Go, A. S., Chang, Y., Hylek, E. M., Henault, L. E., Jensvold, N. G., & Singer, D. E. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.07.034 · Cited by 510
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2013) · Chest · doi:10.1378/chest.13-0054 · Cited by 482
Camm, A. J., Amarenco, P., Haas, S., Hess, S., Kirchhof, P., Kuhls, S., van Eickels, M., & Turpie, A. G. G. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv466 · Cited by 452
Optum Labs: Building A Novel Node In The Learning Health Care System
Wallace, P. J., Shah, N. D., Dennen, T., Bleicher, P. A., & Crown, W. H. (2014) · Health Affairs · doi:10.1377/hlthaff.2014.0038 · Cited by 445
Self-citationBeyer-Westendorf, J., Förster, K., Pannach, S., Ebertz, F., Gelbricht, V., Thieme, C., Michalski, F., Köhler, C., Werth, S., Sahin, K., et al. (2014) · Blood · doi:10.1182/blood-2014-03-563577 · Cited by 407
Larsen, T. B., Rasmussen, L. H., Skjøth, F., Due, K. M., Callréus, T., Rosenzweig, M., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.020 · Cited by 403
An automated database case definition for serious bleeding related to oral anticoagulant use
Cunningham, A., Stein, C. M., Chung, C. P., Daugherty, J. R., Smalley, W. E., & Ray, W. A. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2109 · Cited by 359
Perioperative atrial fibrillation and the long-term risk of ischemic stroke
Gialdini, G., Nearing, K., Bhave, P. D., Bonuccelli, U., Iadecola, C., Healey, J. S., & Kamel, H. (2014) · JAMA · doi:10.1001/jama.2014.9143 · Cited by 355
Abraham, N. S., Singh, S., Alexander, G. C., Heien, H., Haas, L. R., Crown, W., & Shah, N. D. (2015) · BMJ · doi:10.1136/bmj.h1857 · Cited by 347
Self-citationJensen, P. N., Johnson, K., Floyd, J., Heckbert, S. R., Carnahan, R., & Dublin, S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2317 · Cited by 339
Three simple rules to ensure reasonably credible subgroup analyses
Burke, J. F., Sussman, J. B., Kent, D. M., & Hayward, R. A. (2015) · BMJ · doi:10.1136/bmj.h5651 · Cited by 312
Risk of Bleeding With Dabigatran in Atrial Fibrillation
Hernandez, I., Baik, S. H., Piñera, A., & Zhang, Y. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.5398 · Cited by 264
Oldgren, J., Alings, M., Darius, H., Diener, H.-C., Eikelboom, J., Ezekowitz, M. D., Kamensky, G., Reilly, P. A., Yang, S., Yusuf, S., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-10-201111150-00004 · Cited by 198
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
Arnason, T., Wells, P. S., van Walraven, C., & Forster, A. J. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.06.015 · Cited by 192
Maura, G., Blotière, P.-O., Bouillon, K., Billionnet, C., Ricordeau, P., Alla, F., & Zureik, M. (2015) · Circulation · doi:10.1161/circulationaha.115.015710 · Cited by 174
Ezekowitz, M. D., Wallentin, L., Connolly, S. J., Parekh, A., Chernick, M. R., Pogue, J., Aikens, T. H., Yang, S., Reilly, P. A., Lip, G. Y. H., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.973735 · Cited by 170
Olesen, J. B., Sorensen, R., Hansen, M. L., Lamberts, M., Weeke, P., Mikkelsen, A. P., Kober, L., Gislason, G. H., Torp-Pedersen, C., & Fosbol, E. L. (2015) · Europace · doi:10.1093/europace/euu225 · Cited by 164
Zalesak, M., Siu, K., Francis, K. M., Chen, Y. X., Alvrtsyan, H., Rao, Y., Walker, D. R., Sander, S. D., Miyasato, G., Matchar, D. B., et al. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000192 · Cited by 163
Lauffenburger, J. C., Farley, J. F., Gehi, A. K., Rhoney, D. H., Brookhart, M. A., & Fang, G. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001798 · Cited by 158
Gorst‐Rasmussen, A., Skjøth, F., Larsen, T. B., Rasmussen, L. H., Lip, G. Y. H., & Lane, D. A. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12845 · Cited by 157
Diener, H., Aisenberg, J., Ansell, J., Atar, D., BREITHARDT, G. E., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Halperin, J. L., Hohnloser, S. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv643 · Cited by 157
Diener, H., Aisenberg, J., Ansell, J., Atar, D., BREITHARDT, G. E., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Halperin, J. L., Hohnloser, S. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw069 · Cited by 157
National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation
Dlott, J. S., George, R., Huang, X., Odeh, M. A., Kaufman, H. W., Ansell, J., & Hylek, E. M. (2014) · Circulation · doi:10.1161/circulationaha.113.002601 · Cited by 155
Thigpen, J. L., Dillon, C., Forster, K., Henault, L. E., Quinn, E. K., Tripodis, Y., Berger, P. B., Hylek, E. M., & Limdi, N. A. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000371 · Cited by 150
Gayat, E., Resche‐Rigon, M., Mary, J., & Porcher, R. (2012) · Pharmaceutical Statistics · doi:10.1002/pst.537 · Cited by 136
Bykov, K., Bartels, D. B., Huybrechts, K. F., Zint, K., Schneeweiß, S., & Seeger, J. D. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-06-0497 · Cited by 136
Schnee, J. M., Fraeman, K. H., Siu, K., Reynolds, M. W., Collins, J. M., Schwartzman, E., & Villines, T. C. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-06-0453 · Cited by 135
Larsen, T. B., Gorst‐Rasmussen, A., Rasmussen, L. H., Skjøth, F., Rosenzweig, M., & Lip, G. Y. H. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.01.031 · Cited by 125
Romanelli, R. J., Nolting, L., Dolginsky, M., Kym, E., & Orrico, K. B. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002369 · Cited by 114
Steinberg, B. A., Holmes, D. N., Piccini, J. P., Ansell, J., Chang, P., Fonarow, G. C., Gersh, B. J., Mahaffey, K. W., Kowey, P. R., Ezekowitz, M. D., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000535 · Cited by 113
Dabigatran use in elderly patients with atrial fibrillation
Avgil-Tsadok, M., Jackevicius, C. A., Essebag, V., Eisenberg, M. J., Rahme, E., Behlouli, H., & Pilote, L. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0247 · Cited by 99
Noseworthy, P. A., Yao, X., Deshmukh, A. J., Houten, H. V., Sangaralingham, L. R., Siontis, K. C., Piccini, J. P., Asirvatham, S. J., Friedman, P. A., Packer, D. L., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002597 · Cited by 96
Self-citationFactors Driving Anticoagulant Selection in Patients With Atrial Fibrillation in the United States
Lauffenburger, J. C., Farley, J. F., Gehi, A. K., Rhoney, D. H., Brookhart, M. A., & Fang, G. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.01.539 · Cited by 69
Patel, P. A., Zhao, X., Fonarow, G. C., Lytle, B. L., Smith, E. E., Xian, Y., Bhatt, D. L., Peterson, E. D., Schwamm, L. H., & Hernandez, A. F. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.000907 · Cited by 67
International differences in treatment effect: do they really exist and why?†
Pocock, S., Calvo, G., Marrugat, J., Prasad, K., Tavazzi, L., Wallentin, L. C., Zannad, F. M., & Garcia, A. A. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht071 · Cited by 66
Noseworthy, P. A., Kapa, S., Deshmukh, A. J., Madhavan, M., Houten, H. V., Haas, L. R., Mulpuru, S. K., McLeod, C. J., Asirvatham, S. J., Friedman, P. A., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.02.020 · Cited by 62
Self-citationda Graca, B., Filardo, G., & Nicewander, D. A. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.968826 · Cited by 62
Beyer‐Westendorf, J., Gelbricht, V., Förster, K., Ebertz, F., Röllig, D., Schreier, T., Tittl, L., Thieme, C., Hänsel, U., Köhler, C. U., et al. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12391 · Cited by 56
Gaps in Monitoring During Oral Anticoagulation
Rose, A. J., Miller, D. R., Ozonoff, A., Berlowitz, D. R., Ash, A. S., Zhao, S., Reisman, J. I., & Hylek, E. M. (2013) · CHEST Journal · doi:10.1378/chest.12-1119 · Cited by 49
Cutler, T., Chuang, A., Huynh, T. D., Witt, R. G., Branch, J. M., Pon, T. K., & White, R. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.10.1028 · Cited by 49
Korenstra, J., Wijtvliet, P., Veeger, N. J. G. M., Geluk, C. A., Bartels, G. L., Posma, J. L., Piersma-Wichers, M. G., Gelder, I. C. V., Rienstra, M., & Tieleman, R. G. (2016) · EP Europace · doi:10.1093/europace/euv397 · Cited by 45
Potpara, T. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-10-0825 · Cited by 24
Musich, S. A., Cheng, Y., Wang, S. S., Hommer, C. E., Hawkins, K., & Yeh, C. S. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3196-7 · Cited by 19
Cited by
January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.011 · Cited by 2,205
Steffel, J., Collins, R., Antz, M., Cornu, P., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., Rowell, N., et al. (2021) · EP Europace · doi:10.1093/europace/euab065 · Cited by 1,132
Siontis, K. C., Zhang, X., Eckard, A., Bhave, N., Schaubel, D. E., He, K., Tilea, A., Stack, A. G., Balkrishnan, R., Yao, X., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035418 · Cited by 492
Self-citationUninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Calkins, H., Willems, S., Gerstenfeld, E. P., Verma, A., Schilling, R., Hohnloser, S. H., Okumura, K., Serota, H., Nordaby, M., Guiver, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701005 · Cited by 430
Metadata
- Authors
- Yao, X., Abraham, N. S., Sangaralingham, L. R., Bellolio, M. F., McBane, R. D., Shah, N. D., & Noseworthy, P. A.
- Venue
- Journal of the American Heart Association
- Published
- 2016-06-13
- Volume
- 5
- Issue
- 6
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2433454023
- Cited by
- 419
- References
- 67
- FWCI
- 56.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.